UINF:F:F-Multi Units Luxembourg - Lyxor US$ 10Y Inflation Breakeven UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 127.525

Change

+0.32 (+0.25)%

Market Cap

USD 0.23B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-8.18 (-1.36%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.48 (+0.91%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-0.43 (-0.40%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.95 (+0.40%)

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.20%)

USD 43.00B
0ZC:F Zscaler Inc

+2.84 (+1.54%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-2.42 (-1.79%)

USD 24.77B

ETFs Containing UINF:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.28% 45% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.28% 45% F 47% F
Trailing 12 Months  
Capital Gain 10.15% 54% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.15% 51% F 49% F
Trailing 5 Years  
Capital Gain 40.38% 52% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.38% 52% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 8.58% 62% D 61% D-
Dividend Return 8.58% 60% D- 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.43% 74% C 93% A
Risk Adjusted Return 101.83% 91% A- 94% A
Market Capitalization 0.23B 46% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.